Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.

Colonna L, Saleem P, Dondey-Nouvel L, Rein W.

Int Clin Psychopharmacol. 2000 Jan;15(1):13-22.

PMID:
10836281
2.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
3.
4.

[Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].

Chabannes JP, Pelissolo A, Farah S, Gerard D.

Encephale. 1998 Jul-Aug;24(4):386-92. French.

PMID:
9809244
5.

Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group.

Möller HJ, Boyer P, Fleurot O, Rein W.

Psychopharmacology (Berl). 1997 Aug;132(4):396-401.

PMID:
9298518
6.

Amisulpride: progress and outcomes.

Lecrubier Y.

Curr Med Res Opin. 2002;18 Suppl 3:s18-22. Review.

PMID:
12418608
7.

Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.

Olié JP, Spina E, Murray S, Yang R.

Int Clin Psychopharmacol. 2006 May;21(3):143-51.

PMID:
16528136
8.

Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?

Blin O.

Encephale. 2000 Oct;26 Spec No 1:7-11. Review. English, French.

PMID:
11294060
9.

A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.

Mortimer A, Martin S, Lôo H, Peuskens J; SOLIANOL Sudy Group.

Int Clin Psychopharmacol. 2004 Mar;19(2):63-9.

PMID:
15076013
10.

Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.

Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1504-9. Epub 2007 Jul 13.

PMID:
17692448
11.

Safety profile of amisulpride in short- and long-term use.

Rein W, Coulouvrat C, Dondey-Nouvel L.

Acta Psychiatr Scand Suppl. 2000;400:23-7. Review.

PMID:
10823308
12.

Amisulpride: a review of its efficacy in schizophrenia.

Möller HJ.

Acta Psychiatr Scand Suppl. 2000;400:17-22. Review.

PMID:
10823307
14.

A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.

Riedel M, Eich FX, Möller HJ.

Eur Psychiatry. 2009 Apr;24(3):149-53. doi: 10.1016/j.eurpsy.2008.10.005. Epub 2008 Dec 13.

PMID:
19070995
15.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
16.

Amisulpride: a review of its use in the management of schizophrenia.

McKeage K, Plosker GL.

CNS Drugs. 2004;18(13):933-56. Review.

PMID:
15521794
17.

Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.

Bhowmick S, Hazra A, Ghosh M.

Aust N Z J Psychiatry. 2010 Mar;44(3):237-42. doi: 10.3109/00048670903487134.

PMID:
20050717
18.

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.

Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.

Int J Neuropsychopharmacol. 2008 Nov;11(7):985-97. doi: 10.1017/S1461145708008791. Epub 2008 May 9.

PMID:
18466670
19.
20.

Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.

Psarros C, Theleritis CG, Paparrigopoulos TJ, Politis AM, Papadimitriou GN.

Int J Geriatr Psychiatry. 2009 May;24(5):518-22. doi: 10.1002/gps.2146.

PMID:
19072747
Items per page

Supplemental Content

Write to the Help Desk